Ultraviolet light converts propranolol, a nonselective β‐blocker and potential lupus‐inducing drug, into a proinflammatory AhR ligand

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|45|11|3174-3187

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.11, 2015-11, pp. : 3174-3187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Switch of AhR in Repression or Activation of Stem Cell Signaling

By  

Current Signal Transduction Therapy, Vol. 12, Iss. 1, 2017-05 ,pp. : 28-33

Bentham Science Publishers

Access to resources Recommend Favorite

β-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study

By Meisinger C.   Heier M.   Lang O.   Döring A.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1189-1195

Springer Publishing Company

Access to resources Recommend Favorite

Sind supraventrikuläre Reentry-Tachykardien durch den kardioselektiven β-Blocker Esmolol (Brevibloc®) terminierbar?

By Sievers B.   Weismüller P.   Trappe H.-J.  

Intensivmedizin und Notfallmedizin, Vol. 39, Iss. 6, 2002-09 ,pp. : 529-536

Springer Publishing Company

Access to resources Recommend Favorite

Tolerability of β-Blocker Initiation and Titration with Bisoprolol and Carvedilol in Congestive Heart Failure – A Randomized Comparison

By  

Cardiology, Vol. 102, Iss. 3, 2004-09 ,pp. : 160-165

Karger

Access to resources Recommend Favorite

β-Blocker Therapy in the Era of Primary Percutaneous Intervention for ST Elevation Myocardial Infarction

By  

Cardiology, Vol. 132, Iss. 2, 2015-06 ,pp. : 91-100

Karger

Access to resources Recommend Favorite